Lunel-Fabiani, F <br/><br/>
[Use of erythropoietin in the treatment of anemia induced by ribavirin/interferon in patients with hepatitis C].  [electronic resource] 

 -  Pathologie-biologie  Oct 2003 
 - 520-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0369-8114 
<br/><br/><label>Standard No.: </label>10.1016/s0369-8114(03)00169-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Triphosphate--blood<br/>Anemia--chemically induced<br/>Drug Therapy, Combination<br/>Epoetin Alfa<br/>Erythropoietin--therapeutic use<br/>Glutathione--blood<br/>Hepatitis C--blood<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--adverse effects<br/>Recombinant Proteins<br/>Reticulocyte Count<br/>Ribavirin--adverse effects